NFKB1 and metabolic syndrome: Chronic low-grade systematic inflammation is recognized as an essential common factor in the mechanism of MetS [15], while acrolein has the potential capability to activate the NF-κB pathway and serve as a pro-inflammatory mediator in umbilical vein endothelial cells [31].